文献速递慢性肾脏病

血红蛋白水平与主要心血管事件的纵向分析

A longitudinal analysis of haemoglobin levels and major cardiovascular events.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

基于CKD-REIN队列2791例未用ESA的2-5期CKD患者,分析血红蛋白与MACE+的关联。男性呈线性,女性呈J形;血红蛋白10.5 vs 11.5 g/dL时,年轻女性MACE+风险增60%,老年女性增70%,年轻男性增30%,老年男性增20%。

要点

  • 女性CKD患者贫血与MACE+的关联强于男性
  • 血红蛋白10.5 vs 11.5 g/dL,女性风险增60-70%
  • 男性风险增20-30%,呈线性关联

核心结论

  • 在未使用ESA的CKD患者中,女性贫血与MACE+风险增高的关联强于男性,此性别差异应指导贫血纠正试验设计。

主要发现

  • 血红蛋白与MACE+的对数风险在男性呈线性,在女性呈J形。
  • 血红蛋白10.5 vs 11.5 g/dL,年轻女性MACE+风险增60%(HR=1.6,95%CI 1.1-2.4)。
  • 老年女性风险增70%(HR=1.7,95%CI 1.3-2.4),年轻男性增30%(HR=1.3,95%CI 1.1-1.5),老年男性增20%(HR=1.2,95%CI 1.1-1.4)。

临床怎么用

  • 评估CKD贫血相关心血管风险时需考虑性别和年龄差异,女性或需更积极监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND HYPOTHESIS: The standard approach to anaemia in non-dialysis chronic kidney disease (CKD) does not account for potential age- or sex-specific related risks. We assessed differences in the association between haemoglobin and major cardiovascular events (MACE+) in men and women with CKD, by age groups. METHODS: Using 5-year longitudinal data from the Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort, we studied patients with CKD stage 2-5 not treated with erythropoiesis-stimulating agents (ESA). The main outcome was MACE+, defined as cardiovascular death, myocardial infarction, stroke or hospitalization for acute heart failure. Competing events were initiation of kidney replacement therapy and non-cardiovascular death. In each of the four predefined subgroups by sex and age (≤70 versus >70 years at baseline), we estimated hazard ratios (HR) of current values of haemoglobin using a cause-specific Cox model adjusted for current values of glomerular filtration rate and transferrin saturation. All current values of biomarkers were first estimated in a multivariate-shared random effect joint model. RESULTS: Analyses considered 29 042 haemoglobin measurements from 2791 patients, and 364 MACE+. The association between current haemoglobin and log hazard of MACE+ was linear in men and J-shaped in women. For a haemoglobin of 10.5 g/dL, as compared with 11.5 g/dL, the hazard of MACE+ at any time was increased by 60% in younger women [HR = 1.6, 95% confidence interval (CI) 1.1-2.4], 70% in older women (HR = 1.7, 95% CI 1.3-2.4), 30% in younger men (HR = 1.3 95% CI 1.1-1.5) and 20% in older men (HR = 1.2 95% CI 1.1-1.4). Results were similar in the sensitivity analysis not censoring at the first ESA treatment. CONCLUSION: Our longitudinal analysis in patients with CKD not on ESA therapy highlights a stronger association between anaemia and increased hazard of MACE+ in women than in men. This sex difference should inform the design of trials addressing anaemia correction in CKD.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Le Gall L, Alencar de Pinho N, Harambat J, et al. A longitudinal analysis of haemoglobin levels and major cardiovascular events. Nephrol Dial Transplant. 2026. PMID: 41206758. doi:10.1093/ndt/gfaf221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。